| Michael Sisitsky, MD | |
|
101 Dudley St., Women And Infants Hospital-division Of Triage, Providence, RI 02905 | |
| (401) 274-1000 | |
| (401) 459-1000 |
| Full Name | Michael Sisitsky |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 37 Years |
| Location | 101 Dudley St., Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316046063 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Affinity Physicians Llc. | 0244413391 | 619 |
News Archive
Scientists at the Stanford University School of Medicine and at UC-San Francisco have succeeded in isolating stem cells from human testes.
MedShape Solutions, Inc., the industry leader in innovative shape memory orthopedic devices, today announced the introduction and first human clinical use of ExoShape™ CL, a two-part PEEK Altera™ interference fixation device that simplifies and improves soft tissue graft fixation during anterior cruciate ligament (ACL) reconstructive surgery.
Anesiva, Inc. announced today that on December 2, 2009, Anesiva received a letter from The NASDAQ Stock Market ("Nasdaq") stating that Anesiva was required to maintain a minimum Market Value of Publicly Held Shares (MVPHS) of $5,000,000 during the last 30 consecutive business days and that therefore
Osiris Therapeutics, Inc., the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and orthopedic areas, announced today its results for the first quarter of fiscal 2010.
› Verified 4 days ago
| Entity Name | Affinity Physicians Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184944662 PECOS PAC ID: 0244413391 Enrollment ID: O20110326000053 |
News Archive
Scientists at the Stanford University School of Medicine and at UC-San Francisco have succeeded in isolating stem cells from human testes.
MedShape Solutions, Inc., the industry leader in innovative shape memory orthopedic devices, today announced the introduction and first human clinical use of ExoShape™ CL, a two-part PEEK Altera™ interference fixation device that simplifies and improves soft tissue graft fixation during anterior cruciate ligament (ACL) reconstructive surgery.
Anesiva, Inc. announced today that on December 2, 2009, Anesiva received a letter from The NASDAQ Stock Market ("Nasdaq") stating that Anesiva was required to maintain a minimum Market Value of Publicly Held Shares (MVPHS) of $5,000,000 during the last 30 consecutive business days and that therefore
Osiris Therapeutics, Inc., the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and orthopedic areas, announced today its results for the first quarter of fiscal 2010.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Sisitsky, MD 101 Dudley St., Women And Infants Hospital-division Of Triage, Providence, RI 02905 Ph: (401) 274-1000 | Michael Sisitsky, MD 101 Dudley St., Women And Infants Hospital-division Of Triage, Providence, RI 02905 Ph: (401) 274-1000 |
News Archive
Scientists at the Stanford University School of Medicine and at UC-San Francisco have succeeded in isolating stem cells from human testes.
MedShape Solutions, Inc., the industry leader in innovative shape memory orthopedic devices, today announced the introduction and first human clinical use of ExoShape™ CL, a two-part PEEK Altera™ interference fixation device that simplifies and improves soft tissue graft fixation during anterior cruciate ligament (ACL) reconstructive surgery.
Anesiva, Inc. announced today that on December 2, 2009, Anesiva received a letter from The NASDAQ Stock Market ("Nasdaq") stating that Anesiva was required to maintain a minimum Market Value of Publicly Held Shares (MVPHS) of $5,000,000 during the last 30 consecutive business days and that therefore
Osiris Therapeutics, Inc., the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and orthopedic areas, announced today its results for the first quarter of fiscal 2010.
› Verified 4 days ago
Donald Ramos, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 695 Eddy St, Providence, RI 02903 Phone: 401-272-1550 Fax: 401-421-8792 | |
Brittany S Hampton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1100 | |
Dr. Jane R. Sharp, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 297 Promenade St, Providence, RI 02908 Phone: 401-490-6464 | |
Dr. Katharine D Wenstrom, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 101 Dudley Street, 3rd Floor, Women & Infants Hospital Of Rhode Island/mfm Division, Providence, RI 02905 Phone: 401-274-1122 Fax: 401-453-7622 | |
Rebecca Crichton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1122 | |
Heather A Smith, MD, MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1122 | |
Meena Theva, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1122 |